About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5460854
Allelic
Composition
Calcatm1.1(cre/ERT2)Ptch/Calca+
Trp53tm1Brn/Trp53tm1Brn
Rb1tm2Brn/Rb1tm2Brn
Ptentm1Hwu/Ptentm1Hwu
Genetic
Background
involves: 129 * 129P2/OlaHsd * 129S4/SvJae * BALB/c * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Calcatm1.1(cre/ERT2)Ptch mutation (0 available); any Calca mutation (24 available)
Ptentm1Hwu mutation (17 available); any Pten mutation (86 available)
Rb1tm2Brn mutation (2 available); any Rb1 mutation (116 available)
Trp53tm1Brn mutation (20 available); any Trp53 mutation (237 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• death within 3 months of tamoxifen treatment

respiratory system
• small cell lung tumors 2.5 months after tamoxifen treatment
• increased proliferation of pulmonary neuroendocrine cells

neoplasm
• all mice develop thyroid tumors
• increased invasiveness at 2.5 months after tamoxifen treatment
• small cell lung tumors 2.5 months after tamoxifen treatment

endocrine/exocrine glands
• all mice develop thyroid tumors


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
01/13/2026
MGI 6.24
The Jackson Laboratory